Araim Pharmaceuticals, Inc.
Records under this name other than patents Araim Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Araim Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,853,358 | Tissue Protective Peptides and Peptide Analogs for Preventing and Treating Diseases and Disorders Associated with Tissue Damage Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,580,465 | Tissue Protective Peptides and Peptide Analogs for Preventing and Treating Diseases and Disorders Associated with Tissue Damage Lapsed on the fee record Ended Feb 28, 2025 · High confidence | Lapsed on the fee record | Ended Feb 28, 2025 | High confidence |
| US 10,864,253 | Tissue Protective Peptides for Preventing and Treating Diseases and Disorders Associated with Tissue Damage Lapsed on the fee record Ended Dec 15, 2024 · High confidence | Lapsed on the fee record | Ended Dec 15, 2024 | High confidence |
| US 9,340,598 | Tissue Protective Peptides and Uses Thereof Lapsed on the fee record Ended May 17, 2024 · High confidence | Lapsed on the fee record | Ended May 17, 2024 | High confidence |
| US 8,071,554 | Tissue Protective Peptides and Uses Thereof Lapsed on the fee record Ended Dec 6, 2023 · High confidence | Lapsed on the fee record | Ended Dec 6, 2023 | High confidence |
| US 10,100,096 | Tissue Protective Peptides and Uses Thereof Lapsed on the fee record Ended Oct 16, 2022 · High confidence | Lapsed on the fee record | Ended Oct 16, 2022 | High confidence |
| US 8,716,245 | Tissue Protective Peptides and Uses Thereof Lapsed on the fee record Ended May 6, 2022 · High confidence | Lapsed on the fee record | Ended May 6, 2022 | High confidence |
| US 8,673,861 | Tissue Protective Peptides and Uses Thereof Lapsed on the fee record Ended Mar 18, 2022 · High confidence | Lapsed on the fee record | Ended Mar 18, 2022 | High confidence |